Because the ubiquitination of proteins may be influenced by phosphorylation and because the multi-tyrosine kinase inhibitor sorafenib has been used in the treatment of aggressive thyroid cancers [32], experiments were performed to examine whether a kinase may be involved in the ubiquitination of VEGFR2 in thyroid cancer cells [31]. Here, KDR is linked to thyroid gland carcinoma.